Pathophysiology of hypertension in SHR is due to overall changes in RAS components, such as renin activity, ACE activity, angiotensin II content, AT1 receptor expression, and NADPH oxidase activity [12,25,26]. The gene discussed is FMO5; the disease is Hypertension.